EUVIMEDEUVIMED entdecken
LeserbriefFallbericht

Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus

Thomas J Tull iD, Emma C Benton, Kristina Semkova, Natalie A Watson, John B Mee, Begona Lopez, Jane Setterfield, Barbara Carey, Sajjad Ahmad, Scott J Robbie, Richard W Groves, Giovanni Sanna und 1 weitere

British Journal of Dermatology · 2024

DOI: 10.1093/bjd/ljae141 ↗

Kurz gefasst

Leserbrief in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Thomas J Tull und 12 weiteren Autor:innen. Beteiligte Einrichtung: St John's Institute of Dermatology. Hauptthemen laut MEDLINE: Rituximab, Lupus Erythematosus, Systemic, Antibodies, Monoclonal, Humanized, Drug Therapy, Combination. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report two cases of recalcitrant epidermolysis bullosa aquisita with associated systemic lupus erythematosus treated with combination rituximab and belimumab therapy. This resulted in the complete resolution of cutaneous lesions and a partial response of the mucosal lesions. These cases support the use of combined rituximab and belimumab for the treatment of recalcitrant immunobullous disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RituximabLupus Erythematosus, SystemicAntibodies, Monoclonal, HumanizedDrug Therapy, CombinationHumansFemaleTreatment OutcomeEpidermolysis BullosaImmunosuppressive AgentsAdult

Substanzen

RituximabAntibodies, Monoclonal, HumanizedbelimumabImmunosuppressive Agents

Autor:innen und Institutionen

  • St John's Institute of Dermatology.
  • Ear, Nose and Throat Department.
  • Louise Coote Lupus Unit.
  • Moorfields Eye Hospital NHS Foundation Trust, London, UK.
  • Department of Ophthalmology, Guy's and St Thomas' NHS Foundation Trust.

ORCID-Profile: Thomas J Tull

Zitieren

APA

Tull, T. J., Benton, E. C., Semkova, K., Watson, N. A., Mee, J. B., Lopez, B., Setterfield, J., Carey, B., Ahmad, S., Robbie, S. J., Groves, R. W., Sanna, G., & D'Cruz, D. P. (2024). Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae141

Vancouver

Tull TJ, Benton EC, Semkova K, Watson NA, Mee JB, Lopez B, et al. Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae141

BibTeX
@article{Tull2024,
  author = {Tull, Thomas J and Benton, Emma C and Semkova, Kristina and Watson, Natalie A and Mee, John B and Lopez, Begona and Setterfield, Jane and Carey, Barbara and Ahmad, Sajjad and Robbie, Scott J and Groves, Richard W and Sanna, Giovanni and D'Cruz, David P},
  title = {Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus},
  journal = {British Journal of Dermatology},
  year = {2024},
  doi = {10.1093/bjd/ljae141}
}
Kostenlos starten →